Idiopathic pulmonary haemosiderosis in paediatric patients : how to make an early diagnosis by L. Castellazzi et al.
CASE REPORT Open Access
Idiopathic pulmonary haemosiderosis in
paediatric patients: how to make an early
diagnosis
Luca Castellazzi1, Maria Francesca Patria1, Gemma Frati1, Andrea Alessandro Esposito2 and Susanna Esposito1*
Abstract
Background: Idiopathic pulmonary haemosiderosis (IPH) is a rare but potentially lethal condition in paediatric patients.
This condition is considered an immune-mediated disorder, but its pathogenesis is still unknown. Idiopathic pulmonary
haemosiderosis is characterized by the classical triad of haemoptysis, iron-deficiency anaemia, and diffuse parenchymal
consolidation on chest radiology. Unfortunately, this triad of signs is not frequent in children at the onset of this
disease, resulting in a delay in diagnosis and a negative outcome.
Case presentation: This case report describes a 4-year-old girl who was admitted for an acute episode of lower
respiratory tract infection associated with severe dyspnoea, polypnoea, and severe anaemia (haemoglobin levels,
5.9 g/dL). She had a history of previous similar episodes, with anaemia treated unsuccessfully with iron supplementation
and managed through repeated blood transfusions in the acute phase. She did not experience haemoptysis. A
computed tomography (CT) scan of the thorax showed ground-glass opacity suggestive of pulmonary haemorrhage.
After other causes of intra-alveolar haemorrhage were excluded, IPH was confirmed by the presence of siderophages
in bronchoalveolar lavage. Immunosuppressive corticosteroid treatment was immediately started with a good
clinical response.
Conclusion: This case highlights the fact that IPH should be suspected in children with recurrent lower respiratory
tract infections who have a history of iron-deficiency anaemia who shows no signs of improvement with iron
supplementation and may require repeated blood transfusions. The absence of haemoptysis does not exclude
the diagnosis of IPH in children. An early and prompt diagnosis is recommended in order to start adequate
immunosuppressive treatment.
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Background
Idiopathic pulmonary haemosiderosis (IPH) is a rare
clinical condition in paediatric patients. Its incidence is
approximately 0.24-1.23 cases per million, with a mor-
tality rate of 50 % [1]. This condition is characterized
by recurrent episodes of diffuse alveolar haemorrhage
and subsequent abnormal haemosiderin accumulation
in pulmonary macrophages, which leads to a thickening
of the alveolar basement membrane and, finally, to
interstitial fibrosis [2]. Its classical triad of signs at
presentation include haemoptysis, iron-deficiency an-
aemia, and diffuse parenchymal lung consolidation. A
delay in diagnosis could lead to a negative prognosis
due to the worsening of pulmonary fibrosis and subse-
quent lethal restrictive lung disease.
In Italy, few cases of IPH have been reported and suc-
cessful management with immunosuppressive regimens
including high dose corticosteroids [2, 3], corticosteroids
plus azathioprine [4], or hydroxychloroquine [5] has been
described. In addition, a recent review highlighted how
the advances in our understanding of IPH have facilitated
its diagnosis and management [6].
This case report describes a child with incomplete
signs of IPH and discusses presentations that could
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permit the early diagnosis and management of IPH in
paediatric patients.
Case presentation
A 4-year-old girl was admitted to our paediatric depart-
ment from another general hospital for an acute episode
of lower respiratory tract infection associated with severe
dyspnoea, polypnoea, and severe anaemia (haemoglobin
level, 5.9 g/dL).
The child was born prematurely at 28 weeks of gesta-
tion with an extremely low birth weight (700 g). She had
suffered from iron-deficiency anaemia since the age of
3 months and was treated with the oral administration
of iron. She also experienced recurrent lower respiratory
tract infections, with a significant worsening of anaemia
concomitant with four of these episodes (for which she
required hospital admission for blood transfusion).
At admission in our ward, the physical findings were as
follows: body weight - 10.9 kg; height - 95 cm (<3rd per-
centile); heart rate - 124 beats/min; respiratory rate - 50
breaths/min; oxygen saturation in the room air - 78 %;
blood pressure - 111/71 mmHg; body temperature -
36.6 °C. She was dyspnoeic. Furthermore, blood exams
revealed the above-mentioned severe anaemia, a mean
corpuscular volume of 67 fL, a reticulocyte count of
3 %, and serum iron (20 μg/dL) and ferritin (8 ng/mL)
levels below the normal range. Direct and indirect
Coombs tests were negative, and main causes of blood
loss and haemolysis were excluded. The coagulation
tests and platelet count were normal, and C-reactive
protein was mildly increased (3.07 mg/dL; normal
value, < 0.5 mg/dL). Serologic tests for immunologic
evaluation and autoimmune diseases (i.e., immunoglob-
ulins, anti-nuclear antibodies, anti-DNA antibodies,
anti-neutrophil cytoplasmic antibodies, anti-cardiolipin
antibodies, anti-smooth muscle antibodies, extractable
nuclear antigen, anti-mitochondrial antibodies, anti-
myeloperoxidase antibodies, and anti-proteinase 3 anti-
bodies) were performed, and the results were negative.
Celiac screening and specific cow’s milk IgE test results
were also negative. Bone marrow aspirate showed hy-
perplastic erythropoiesis. A prompt blood transfusion
was performed, oxygen with high-flow nasal cannulae
was immediately administered, and i.v. cefotaxime
treatment (100 mg/kg/day in three doses for 8 days)
was started.
A computed tomography (CT) scan of the thorax was
performed and showed a diffuse ground-glass opacity
suggestive of pulmonary haemorrhage (Fig. 1). Clinical
history (i.e., severe persistent anaemia that worsened
during lower respiratory tract infections) and radiologic
findings resulted in the suspicion of pulmonary haemosi-
derosis. A bronchoalveolar lavage was requested and
showed the presence of haemosiderin-laden macrophages
(siderophages). Thus, idiopathic pulmonary haemosidero-
sis was diagnosed, and intravenous methylprednisolone
(20 mg/kg/day for 3 days) was immediately administered,
with a prompt improvement in respiratory symptoms and
stabilization of haematological data. Then, oral prednisone
(1 mg/kg/day) was started and was well tolerated by
the child.
After 6 months of follow-up, the child was still receiving
oral prednisone (1 mg/kg/day), had not experienced any
exacerbations of the disease and had a haemoglobin level
in the normal range.
Discussion
IPH is a rare clinical condition in paediatric patients.
The age at presentation has a bimodal distribution, with
a first peak in children less than 5 years old and a second
peak in children older than 11 years [1]. No difference in
gender distribution is observed in children, whereas this
condition mainly occurs in males in the adult population
[7]. The rarity of this disease and the variable clinical
course results in many diagnostic pitfalls especially in chil-
dren [6]. The aetiology of IPH is not yet known, although
it is considered an immune-mediated disorder. Different
triggers in predisposed children are associated with the
Fig. 1 Pulmonary haemorrhage associated with idiopathic pulmonary haemosiderosis. a Axial computed tomography (CT) scan at the level of the
lower lobes of the thorax (pulmonary window). b Axial CT scan at the level of the upper lobes of the thorax (pulmonary window). The images
show diffuse ground-glass opacity associated with fine reticulation, findings characteristic of pulmonary haemorrhage. The predominant findings
in the acute phase of idiopathic pulmonary haemosiderosis also include diffuse nodules (black arrows)
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development of IPH, such as infections (especially respira-
tory tract infections), cow’s milk protein allergy and celiac
disease [8–11]. Some reports have highlighted the frequent
association between Down syndrome and the development
of IPH probably because children with this condition are
more prone to develop autoimmune diseases, especially
celiac disease [12]. Recently, IPH was also described in a
child with selective immunoglobulin A deficiency, a condi-
tion that is known to predispose individuals to the devel-
opment of autoimmune disorders [13].
IPH is characterized by recurrent episodes of intra-
alveolar haemorrhage, which causes the abnormal accu-
mulation of haemosiderin in alveolar macrophages. These
macrophages release pro-inflammatory cytokines that
cause chronic inflammation and interstitial fibrosis of the
lungs [14]. The classical triad of clinical presentation,
characterized by iron-deficiency anaemia, recurrent haem-
optysis and diffuse parenchymal consolidation on chest
radiograph, is not always present in children with IPH
[15]. A French study reported that the most frequent clin-
ical features in paediatric patients at disease diagnosis
were anaemia and dyspnoea (64 % and 68 %, respectively),
whereas haemoptysis occurred in only 50 % of the patients
[12]. Haemoptysis is rare in children because in most
cases they are not able to expectorate [12, 16]. Iron-
deficiency anaemia could precede other signs and symp-
toms by several months in children with IPH and could
be severe enough to necessitate a blood transfusion des-
pite adequate iron supplementation [1, 15, 17, 18]. Other
frequent signs in IPH are recurrent lower respiratory tract
infections and recurrent tachypnoea [14, 16]. In children
who have recurrent lower respiratory tract infections with
persistent severe anaemia despite adequate iron supple-
mentation, IPH may be suspected after the exclusion of
possible causes of blood loss [1, 14].
A prompt diagnosis of IPH is crucial for early treat-
ment in order to improve the prognosis. Unfortunately,
delayed diagnosis is frequently reported, with a delay
period of 4 months – 10 years [19]. This delay may be
attributed to different reasons, primarily including the
insidious onset and a lack of awareness of IPH. The
diagnosis of IPH is mainly a diagnosis of exclusion.
Diagnosis of IPH is based on exclusion of other causes
of intrapulmonary haemorrhage and systemic diseases.
When children present with unexplained anemia and bi-
lateral lung infiltrations, pulmonary haemorrhage should
be suspected [6]. In addition, autoimmune diseases and
coagulation disorders should be excluded [20]. Further-
more, considering the association of IPH with celiac
disease and cow’s milk protein allergy, screening for
these conditions should be performed in all patients
[12]. The gold standard for the diagnosis of IPH is con-
sidered lung biopsy, but this method is invasive and not
practiced everywhere in children [6]. Even our patient
did not perform lung biopsy, although this diagnostic
method is useful to exclude other causes of interstitial
lung diseases. Another specific and sensitive method
for the diagnosis of IPH is bronchoalveolar lavage ana-
lysis, which permits the confirmation of the diagnosis
with a high percentage of haemosiderin-laden macro-
phages (siderophages) [21]. Recently, some authors
highlighted the fact that the search for siderophages
can also be completed by gastric lavage fluid analysis,
which is a simple and reliable test that can be used in
children [1].
Immunosuppressive agents are the treatment of choice
for IPH, despite the lack of large controlled studies on this
topic. High doses of steroids are considered the first line
of treatment in IPH to reduce episodes of haemorrhage
and bleeding. In cases that are not completely controlled
by steroids or in those patients who experience side effects
to these drugs, other immunosuppressive agents such
as azathioprine, chloroquine, cyclophosphamide and 6-
mercaptopurine have to be considered [12, 22–25]. The
prognosis of patients with IPH, which has improved in
the last years, is influenced by several factors, including
the time of diagnosis, the early initiation of treatment
and the presence of comorbidities [15].
Conclusion
In conclusion, this case report highlights the fact that
IPH should be suspected in children with recurrent
lower respiratory tract infections who have a history of
iron-deficiency anaemia, who shows no signs of im-
provement with iron supplementation and may require
repeated blood transfusions. Haemoptysis, which is con-
sidered a classical sign of IPH, is rare in children, and its
absence does not exclude the diagnosis of IPH. An early
and prompt diagnosis is recommended to start adequate
immunosuppressive treatment.
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